Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2

Serine proteases has been considered to be closely associated with the inflammatory response and tumor progression. As a novel serine protease, the biological function of PRSS23 is rarely studied in cancers. In this study, the prognostic significance of PRSS23 was analyzed in two-independent gastric...

Full description

Bibliographic Details
Main Authors: Shanshan Qin, Zidi Wang, Congcong Huang, Pan Huang, Dandan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.955841/full
_version_ 1811267866509443072
author Shanshan Qin
Shanshan Qin
Zidi Wang
Congcong Huang
Congcong Huang
Pan Huang
Pan Huang
Dandan Li
Dandan Li
author_facet Shanshan Qin
Shanshan Qin
Zidi Wang
Congcong Huang
Congcong Huang
Pan Huang
Pan Huang
Dandan Li
Dandan Li
author_sort Shanshan Qin
collection DOAJ
description Serine proteases has been considered to be closely associated with the inflammatory response and tumor progression. As a novel serine protease, the biological function of PRSS23 is rarely studied in cancers. In this study, the prognostic significance of PRSS23 was analyzed in two-independent gastric cancer (GC) cohorts. PRSS23 overexpression was clinically correlated with poor prognosis and macrophage infiltration of GC patients. Loss-of-function study verified that PRSS23 plays oncogenic role in GC. RNA-seq, qRT-PCR, western blotting and ELISA assay confirmed that serine protease PRSS23 positively regulated FGF2 expression and secretion. Single-cell analysis and gene expression correlation analysis showed that PRSS23 and FGF2 were high expressed in fibroblasts, and highly co-expressed with the biomarkers of tumor associated macrophages (TAMs), cancer-associated fibroblasts (CAFs) and mesenchymal cells. Functional analysis confirmed PRSS23/FGF2 was required for TAM infiltration. Rescue assay further verified that PRSS23 promotes GC progression and TAM infiltration through FGF2. Survival analysis showed that high infiltration of M1-macrophage predicted favorable prognosis, while high infiltration level of M2-macrophage predicted poor prognosis in GC. Our finding highlights that PRSS23 promotes TAM infiltration through regulating FGF2 expression and secretion, thereby resulting in a poor prognosis.
first_indexed 2024-04-12T21:10:19Z
format Article
id doaj.art-3d9827197a68483abe5658097ae3d908
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T21:10:19Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-3d9827197a68483abe5658097ae3d9082022-12-22T03:16:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.955841955841Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2Shanshan Qin0Shanshan Qin1Zidi Wang2Congcong Huang3Congcong Huang4Pan Huang5Pan Huang6Dandan Li7Dandan Li8Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaLaboratory of Tumor Biology, Academy of Bio-Medicine Research, Hubei University of Medicine, Shiyan, ChinaLaboratory of Tumor Biology, Academy of Bio-Medicine Research, Hubei University of Medicine, Shiyan, ChinaHubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaLaboratory of Tumor Biology, Academy of Bio-Medicine Research, Hubei University of Medicine, Shiyan, ChinaHubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaLaboratory of Tumor Biology, Academy of Bio-Medicine Research, Hubei University of Medicine, Shiyan, ChinaHubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaLaboratory of Tumor Biology, Academy of Bio-Medicine Research, Hubei University of Medicine, Shiyan, ChinaSerine proteases has been considered to be closely associated with the inflammatory response and tumor progression. As a novel serine protease, the biological function of PRSS23 is rarely studied in cancers. In this study, the prognostic significance of PRSS23 was analyzed in two-independent gastric cancer (GC) cohorts. PRSS23 overexpression was clinically correlated with poor prognosis and macrophage infiltration of GC patients. Loss-of-function study verified that PRSS23 plays oncogenic role in GC. RNA-seq, qRT-PCR, western blotting and ELISA assay confirmed that serine protease PRSS23 positively regulated FGF2 expression and secretion. Single-cell analysis and gene expression correlation analysis showed that PRSS23 and FGF2 were high expressed in fibroblasts, and highly co-expressed with the biomarkers of tumor associated macrophages (TAMs), cancer-associated fibroblasts (CAFs) and mesenchymal cells. Functional analysis confirmed PRSS23/FGF2 was required for TAM infiltration. Rescue assay further verified that PRSS23 promotes GC progression and TAM infiltration through FGF2. Survival analysis showed that high infiltration of M1-macrophage predicted favorable prognosis, while high infiltration level of M2-macrophage predicted poor prognosis in GC. Our finding highlights that PRSS23 promotes TAM infiltration through regulating FGF2 expression and secretion, thereby resulting in a poor prognosis.https://www.frontiersin.org/articles/10.3389/fimmu.2022.955841/fullserine protease PRSS23FGF2macrophage infiltrationTAMgastric cancer
spellingShingle Shanshan Qin
Shanshan Qin
Zidi Wang
Congcong Huang
Congcong Huang
Pan Huang
Pan Huang
Dandan Li
Dandan Li
Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2
Frontiers in Immunology
serine protease PRSS23
FGF2
macrophage infiltration
TAM
gastric cancer
title Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2
title_full Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2
title_fullStr Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2
title_full_unstemmed Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2
title_short Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2
title_sort serine protease prss23 drives gastric cancer by enhancing tumor associated macrophage infiltration via fgf2
topic serine protease PRSS23
FGF2
macrophage infiltration
TAM
gastric cancer
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.955841/full
work_keys_str_mv AT shanshanqin serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT shanshanqin serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT zidiwang serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT congconghuang serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT congconghuang serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT panhuang serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT panhuang serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT dandanli serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2
AT dandanli serineproteaseprss23drivesgastriccancerbyenhancingtumorassociatedmacrophageinfiltrationviafgf2